Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics
Journal of Experimental Neuroscience · 2018-01 · 12
DOI: 10.1177/1179069518800508 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Neuroscience, online erschienen am 19.09.2018. Verfasst von David E Olson. Beteiligte Einrichtung: Department of Chemistry, University of California, Davis, Davis, CA, USA. Die Arbeit wurde bisher 236-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NICHD NIH HHS, National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Neural plasticity—the ability to change and adapt in response to stimuli—is an essential aspect of healthy brain function and, in principle, can be harnessed to promote recovery from a wide variety of brain disorders. Many neuropsychiatric diseases including mood, anxiety, and substance use disorders arise from an inability to weaken and/or strengthen pathologic and beneficial circuits, respectively, ultimately leading to maladaptive behavioral responses. Thus, compounds capable of facilitating the structural and functional reorganization of neural circuits to produce positive behavioral effects have broad therapeutic potential. Several known drugs and experimental therapeutics have been shown to promote plasticity, but most rely on indirect mechanisms and are slow-acting. Here, I describe psychoplastogens—a relatively new class of fast-acting therapeutics, capable of rapidly promoting structural and functional neural plasticity. Psychoplastogenic compounds include psychedelics, ketamine, and several other recently discovered fast-acting antidepressants. Their use in psychiatry represents a paradigm shift in our approach to treating brain disorders as we focus less on rectifying “chemical imbalances” and place more emphasis on achieving selective modulation of neural circuits.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemistry, University of California, Davis, Davis, CA, USA.
- Department of Biochemistry & Molecular Medicine, School of Medicine, University of California, Davis, Sacramento, CA, USA.
- Center for Neuroscience, University of California, Davis, Davis, CA, USA.
ORCID-Profile: David E Olson
Förderung
- NIGMS NIH HHS
- NICHD NIH HHS
- National Institute of Child Health and Human Development
- National Institute of General Medical Sciences
- University of California, Davis
Zitieren
APA
Olson, D. E. (2018). Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics. Journal of Experimental Neuroscience, 12. https://doi.org/10.1177/1179069518800508
Vancouver
Olson DE. Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics. Journal of Experimental Neuroscience. 2018;12. doi:10.1177/1179069518800508
BibTeX
@article{Olson2018,
author = {Olson, David E},
title = {Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics},
journal = {Journal of Experimental Neuroscience},
year = {2018},
volume = {12},
doi = {10.1177/1179069518800508}
}
EUVIMED